
Scientist Downstream Process Development | VectorY

Production Specialist | FrieslandCampina

Management Assistent | FrieslandCampina

Improve Engineer | Avient

Warehouse Operator Spareparts | Marel

Receptioniste | DSM-Firmenich

Operator Packaging | FrieslandCampina

Safety & Health Supervisor | NISSAN
Scientist Downstream Process Development | VectorY
Work for an Organization that brings innovative therapies to patients worldwide.
VectorY combines the potential of antibodies and gene therapy to develop long-lasting therapeutic solutions for disease areas of high unmet medical need.
Founded in August 2020, and based in the Amsterdam Science Park, VectorY is a fully integrated gene therapy company focused on the development of innovative therapeutics.
With R&D facilities in Amsterdam, VectorY develops proprietary & partnered programs based on its novel AAV-based vectorized antibody gene therapy platform. Next generation vector technologies are applied to develop product candidates, which will enable a proprietary and highly scalable manufacturing process.
Your position within the organization
The Process Development (PD) department is an essential part of VectorY, which is taking the lead for the in-house development, scale-up and manufacture of novel gene therapies. The downstream processing (DSP) team is responsible for recovering and purifying the biopharmaceutical from the bioreactor harvest through a sequence of unit operations, including cell lysis, filtration, chromatography, and UF/DF. The DSP team will also support tech transfer to Contract Manufacturing Organizations (CMOs) for the manufacture of AAV-based gene therapies for clinical trials.
The main responsibilities of the role
Make study designs to develop and optimize the downstream manufacturing process
Apply Design of Experiments (DoE) to aid efficient process development and use of Quality by Design principles
Process development at a small scale of each unit operation (processing 2 – 16 L harvest)
Scale up and further optimize the manufacturing process to pilot scale (processing 50 L harvest) •
Manage the day-to-day downstream process development execution by a team of technicians
Manage the technical execution of projects to meet the set timelines and deliverables • Develop training plans and mentor (junior) technicians and students
Write SOPs and document the work in study plans and reports. Draft the manufacturing documentation
Secure data management, processing of the results and presentation to key stakeholders
Work collaboratively with scientists in Upstream Process Development, Vector Development and Analytical Development
Skills and Qualifications:
Ph.D., with a minimum of 2 years of relevant working experience
Hands-on experience with small-scale chromatography and ultrafiltration equipment required, preferably with AKTA systems
Industrial experience with the development of the manufacturing process for biopharmaceuticals, such as vaccines or gene therapies is considered a plus
Experience in upstream processing is considered a plus
Your Natural Strengths and Drivers
You are thorough, have strong scientific and organizational skills, and have the ability to distinguish main priorities from lower-priority matters. You deliver well-thought-through study designs and work consistently and at a steady pace.
Working at VectorY
We offer an attractive salary package, 30 holiday days and every opportunity to develop yourself. A personal and authentic experience within a young, ambitious biotech company with a strong and established infrastructure on the path to bring innovative therapies to patients worldwide.

VectorY
VectorY at a glance
Our mission
We are an Amsterdam-based biotech company founded in 2020 with a mission to develop vectorized antibody treatments for people with neurodegenerative diseases, enabling longer, better lives.
Antibody treatments have wide applicability in neurodegenerative diseases that are known to be complex and difficult to treat. Our cutting-edge vectorized antibody technology combines highly selective therapeutic antibodies with one-time AAV-based delivery to the CNS. We are advancing a development pipeline of potentially disease-modifying treatments for ALS, Huntington’s, and Parkinson’s disease.
Our vectorized antibody platform
Our expert team has developed a unique platform with state-of-the-art intracellular antibodies, engineered capsids and scalable AAV manufacturing processes. With this broad in-house expertise our team is uniquely positioned to rapidly discover and develop new therapies.
Our programs
We have a strong pipeline of potentially disease-modifying vectorized antibody treatments for neurodegenerative diseases including ALS, Huntington’s, and Parkinson’s disease.
Strong Leadership
Our leaders on the Management Team, Board of Directors and Scientific Advisory Board have a proven track record in the development of new drugs as well as extensive business and scientific expertise.
Want to know more?
